Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Share a link:
https://casecent.re/p/21962
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is the second of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes Biogen, one of the top biotechnology firms worldwide. Discussion covers activity during the period 1998-1999 including key products, research and development, marketing, competition, and financials. Based in Massachusetts, Biogen rose to success as a result of expertise in molecular biology, cell biology, immunology, and protein chemistry. One in a series of eight cases drawn from public information sources. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
About
Abstract
This is the second of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes Biogen, one of the top biotechnology firms worldwide. Discussion covers activity during the period 1998-1999 including key products, research and development, marketing, competition, and financials. Based in Massachusetts, Biogen rose to success as a result of expertise in molecular biology, cell biology, immunology, and protein chemistry. One in a series of eight cases drawn from public information sources. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.